Zurich Cantonal Bank
VERA icon

Zurich Cantonal Bank’s Vera Therapeutics VERA Stock Holding History

Zurich Cantonal Bank’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$866K Buy
20,176
+279
+1% +$10.4K ﹤0.01% 1633
2026
Q1 		$800K Buy
19,897
+1,273
+7% +$54.8K ﹤0.01% 1561
2025
Q4 		$943K Buy
18,624
+2,391
+15% +$84.9K ﹤0.01% 1383
2025
Q3 		$472K Sell
16,233
-110
-0.7% -$2.54K ﹤0.01% 1772
2025
Q2 		$385K Buy
16,343
+6,810
+71% +$153K ﹤0.01% 1815
2025
Q1 		$229K Buy
9,533
+1,572
+20% +$50.5K ﹤0.01% 2025
2024
Q4 		$337K Buy
7,961
+434
+6% +$19.2K ﹤0.01% 1861
2024
Q3 		$333K Hold
7,527
– – ﹤0.01% 1818
2024
Q2 		$272K Buy
7,527
+1,737
+30% +$68.9K ﹤0.01% 1886
2024
Q1 		$250K Hold
5,790
– – ﹤0.01% 1927
2023
Q4 		$89K Hold
5,790
– – ﹤0.01% 2477
2023
Q3 		$79.4K Buy
+5,790
New +$99.3K ﹤0.01% 2463

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Zurich Cantonal Bank's VERA Position: Q2 2026 in Review

Zurich Cantonal Bank increased its Vera Therapeutics (VERA) stake by 1.4% in Q2 2026, buying an estimated $10.4K and bringing the position to 20,176 shares worth $866K. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Zurich Cantonal Bank first reported a position in VERA in Q3 2023 and has held it in 12 quarters since. The position peaked at $943K in Q4 2025. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Zurich Cantonal Bank held 20,176 shares of Vera Therapeutics worth $866K as of Q2 2026.
  • Zurich Cantonal Bank bought 279 Vera Therapeutics shares in Q2 2026, an estimated $10.4K.
  • Vera Therapeutics made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1633 holding.
  • Zurich Cantonal Bank first reported a position in Vera Therapeutics in Q3 2023 and has held it in 12 quarters since.
  • Zurich Cantonal Bank's Vera Therapeutics position peaked at $943K in Q4 2025.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.